SDHC
Basic information
Region (hg38): 1:161314381-161363206
Previous symbols: [ "PGL3" ]
Links
Phenotypes
GenCC
Source:
- Carney-Stratakis syndrome (Strong), mode of inheritance: AD
- gastrointestinal stromal tumor (Strong), mode of inheritance: AD
- renal cell carcinoma (Moderate), mode of inheritance: AD
- paragangliomas 3 (Strong), mode of inheritance: AD
- Cowden disease (Supportive), mode of inheritance: AD
- hereditary pheochromocytoma-paraganglioma (Supportive), mode of inheritance: AD
- Carney-Stratakis syndrome (Supportive), mode of inheritance: AD
- paragangliomas 3 (Definitive), mode of inheritance: AD
- gastrointestinal stromal tumor (Strong), mode of inheritance: AD
- paragangliomas 3 (Strong), mode of inheritance: AD
- hereditary pheochromocytoma-paraganglioma (Definitive), mode of inheritance: AD
- mitochondrial disease (No Known Disease Relationship), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma/paraganglioma syndrome 3 | AD | Oncologic | The condition involves increased risk of certain types of neoplasms, and surveillance/early treatment of tumors (eg, surgical resection) may be beneficial | Oncologic | 15342702; 15342702; 16249420; 17804857; 17667967; 21173220; 21348866; 22703879 |
ClinVar
This is a list of variants' phenotypes submitted to
- Gastrointestinal stromal tumor;Paragangliomas 3 (21 variants)
- Hereditary cancer-predisposing syndrome (15 variants)
- Paragangliomas 3 (12 variants)
- Paragangliomas 3;Gastrointestinal stromal tumor (10 variants)
- not provided (5 variants)
- Hereditary pheochromocytoma-paraganglioma (4 variants)
- Gastrointestinal stromal tumor (3 variants)
- Carney triad (2 variants)
- Carney-Stratakis syndrome (2 variants)
- Paragangliomas 3;Gastrointestinal stromal tumor;Carney-Stratakis syndrome (1 variants)
- Rhabdomyosarcoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SDHC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 94 | 95 | ||||
missense | 294 | 32 | 333 | |||
nonsense | 12 | |||||
start loss | 6 | |||||
frameshift | 22 | 27 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 21 | 25 | ||||
splice region | 1 | 27 | 26 | 54 | ||
non coding | 25 | 87 | 50 | 163 | ||
Total | 41 | 29 | 330 | 214 | 50 |
Highest pathogenic variant AF is 0.0000263
Variants in SDHC
This is a list of pathogenic ClinVar variants found in the SDHC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-161314392-G-C | not specified | Likely benign (Aug 15, 2023) | ||
1-161314392-G-T | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Aug 08, 2023) | ||
1-161314394-C-G | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (May 16, 2023) | ||
1-161314401-C-A | Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 19, 2022) | ||
1-161314401-C-T | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 01, 2022) | ||
1-161314402-C-G | Hereditary pheochromocytoma-paraganglioma | Uncertain significance (Apr 03, 2023) | ||
1-161314402-C-T | Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 11, 2017) | ||
1-161314403-A-G | Hereditary cancer-predisposing syndrome • SDHC-related disorder | Uncertain significance (Mar 12, 2024) | ||
1-161314405-G-A | Hereditary cancer-predisposing syndrome | Uncertain significance (Nov 06, 2023) | ||
1-161314406-A-C | Paragangliomas 3;Gastrointestinal stromal tumor | Pathogenic (Dec 23, 2021) | ||
1-161314406-A-G | Paragangliomas 3 • Hereditary cancer-predisposing syndrome • Paragangliomas 3;Gastrointestinal stromal tumor | Pathogenic (Feb 15, 2024) | ||
1-161314406-A-T | Paragangliomas 3;Gastrointestinal stromal tumor • Paragangliomas 3 • Hereditary cancer-predisposing syndrome | Pathogenic (May 21, 2024) | ||
1-161314407-T-C | Paragangliomas 3;Gastrointestinal stromal tumor | Pathogenic (Jan 09, 2023) | ||
1-161314407-T-G | Paragangliomas 3;Gastrointestinal stromal tumor | Likely pathogenic (Oct 06, 2019) | ||
1-161314408-G-A | Paragangliomas 3 • Gastrointestinal stromal tumor;Paragangliomas 3 | Pathogenic (Feb 15, 2024) | ||
1-161314409-G-A | Gastrointestinal stromal tumor;Paragangliomas 3 • Gastrointestinal stromal tumor • Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 17, 2023) | ||
1-161314409-G-C | Paragangliomas 3;Gastrointestinal stromal tumor | Uncertain significance (Apr 22, 2023) | ||
1-161314410-C-G | Paragangliomas 3;Gastrointestinal stromal tumor • Gastrointestinal stromal tumor • Hereditary cancer-predisposing syndrome | Uncertain significance (Dec 07, 2023) | ||
1-161314410-C-T | Hereditary cancer-predisposing syndrome • Gastrointestinal stromal tumor;Paragangliomas 3 | Uncertain significance (Nov 02, 2023) | ||
1-161314410-CT-C | Carney triad • Hereditary cancer-predisposing syndrome | Pathogenic (May 08, 2013) | ||
1-161314411-T-A | Paragangliomas 3;Gastrointestinal stromal tumor • Hereditary pheochromocytoma-paraganglioma | Likely benign (Apr 14, 2023) | ||
1-161314411-T-C | Gastrointestinal stromal tumor;Paragangliomas 3 • Hereditary cancer-predisposing syndrome • Hereditary pheochromocytoma-paraganglioma | Likely benign (Dec 18, 2023) | ||
1-161314411-T-G | Paragangliomas 3;Gastrointestinal stromal tumor • Hereditary cancer-predisposing syndrome | Likely benign (Jul 15, 2023) | ||
1-161314412-G-A | Gastrointestinal stromal tumor;Paragangliomas 3 • Hereditary cancer-predisposing syndrome • Gastrointestinal stromal tumor • Hereditary pheochromocytoma-paraganglioma • SDHC-related disorder | Uncertain significance (Feb 01, 2024) | ||
1-161314412-G-C | Paragangliomas 3;Gastrointestinal stromal tumor • Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SDHC | protein_coding | protein_coding | ENST00000367975 | 6 | 48938 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000201 | 0.740 | 125675 | 0 | 21 | 125696 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.825 | 74 | 96.8 | 0.764 | 0.00000533 | 1081 |
Missense in Polyphen | 18 | 29.002 | 0.62064 | 334 | ||
Synonymous | -0.165 | 37 | 35.7 | 1.04 | 0.00000191 | 355 |
Loss of Function | 0.990 | 7 | 10.5 | 0.669 | 6.19e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000292 | 0.0000292 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000126 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q).;
- Disease
- DISEASE: Paragangliomas 3 (PGL3) [MIM:605373]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:11062460}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paraganglioma and gastric stromal sarcoma (PGGSS) [MIM:606864]: Gastrointestinal stromal tumors may be sporadic or inherited in an autosomal dominant manner, alone or as a component of a syndrome associated with other tumors, such as in the context of neurofibromatosis type 1 (NF1). Patients have both gastrointestinal stromal tumors and paragangliomas. Susceptibility to the tumors was inherited in an apparently autosomal dominant manner, with incomplete penetrance. {ECO:0000269|PubMed:17804857}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Citrate cycle (TCA cycle) - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Warburg Effect;Mitochondrial Electron Transport Chain;The oncogenic action of Succinate;The oncogenic action of Fumarate;Pyruvate dehydrogenase deficiency (E3);Pyruvate dehydrogenase deficiency (E2);2-ketoglutarate dehydrogenase complex deficiency;Mitochondrial complex II deficiency;Fumarase deficiency;Congenital lactic acidosis;Citric Acid Cycle;Glutaminolysis and Cancer;The oncogenic action of 2-hydroxyglutarate;The oncogenic action of L-2-hydroxyglutarate in Hydroxygluaricaciduria;The oncogenic action of D-2-hydroxyglutarate in Hydroxygluaricaciduria ;Electron Transport Chain;TCA Cycle;Citrate cycle;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TCA cycle;TCA cycle;Arginine Proline metabolism;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle;Tyrosine metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
(Consensus)
Recessive Scores
- pRec
- 0.354
Intolerance Scores
- loftool
- 0.335
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 75.87
Haploinsufficiency Scores
- pHI
- 0.216
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sdhc
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; skeleton phenotype;
Gene ontology
- Biological process
- tricarboxylic acid cycle;mitochondrial electron transport, succinate to ubiquinone;aerobic respiration;oxidation-reduction process
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone);integral component of membrane;respiratory chain complex II
- Molecular function
- succinate dehydrogenase (ubiquinone) activity;electron transfer activity;heme binding;metal ion binding